FRI0218 Shared epitope positivity is related to efficacy of abatacept in rheumatoid arthritis

BackgroundAbatacept, a soluble fusion protein composed of the extracellular domain of CTLA-4 molecule and the Fc portion of human IgG1, is approved therapy for RA by the mechanism of binding to CD80/86 (B7–1/B7–2) on antigen presenting cell (APC), and blocking the B7:CD28 interaction. Meanwhile, it...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the rheumatic diseases Vol. 76; no. Suppl 2; p. 565
Main Authors Oryoji, K, Yoshida, K, Mizuki, S-I
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group LTD 01.06.2017
Subjects
Online AccessGet full text

Cover

Loading…